Literature DB >> 23256822

Cocrystallization for successful drug delivery.

Changquan Calvin Sun1.   

Abstract

INTRODUCTION: Cocrystallization is an effective crystal engineering approach for modifying the crystal structure and properties of drugs. The number of examples of solving drug formulation and manufacture problems by cocrystallization is rapidly growing. An updated review that systematically examines the cocrystal research in the context of drug delivery is timely and valuable. AREAS COVERED: Topics covered in this review include nature of cocrystal, impact of cocrystallization on key pharmaceutical properties (both enhancement and deterioration), cocrystal preparation method and future directions in this field. The focus of this review is on the crystal engineering and pharmaceutical literature in the last 5 years. However, classical literature is also examined when relevant. EXPERT OPINION: The most effective cocrystal research relies on both in-depth understanding of structure-property relationship and efficient preparation of desired cocrystals. The future cocrystal research will see growth in the areas of designing ternary and higher-order structures, cocrystals between neutral and ionic species, cocrystal polymorphism, cocrystal glasses and thermodynamics of cocrystallization.

Mesh:

Substances:

Year:  2012        PMID: 23256822     DOI: 10.1517/17425247.2013.747508

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  23 in total

Review 1.  Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.

Authors:  Dipak Dilip Gadade; Sanjay Sudhakar Pekamwar
Journal:  Adv Pharm Bull       Date:  2016-12-22

Review 2.  Application of UV Imaging in Formulation Development.

Authors:  Yu Sun; Jesper Østergaard
Journal:  Pharm Res       Date:  2016-10-20       Impact factor: 4.200

3.  Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.

Authors:  Hiroyuki Yamashita; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2017-12-29       Impact factor: 4.200

4.  Novel Co-crystals and Eutectics of Febuxostat: Characterization, Mechanism of Formation, and Improved Dissolution.

Authors:  Moksh Jagia; Dnyaneshwar P Kale; Arvind Kumar Bansal; Sarsvatkumar Patel
Journal:  AAPS PharmSciTech       Date:  2021-12-29       Impact factor: 3.246

5.  Recrystallization of Adenosine for Localized Drug Delivery.

Authors:  Ketki Y Velankar; Mingyao Mou; Paul R Hartmeier; Benjamin Clegg; Ellen S Gawalt; Mo Jiang; Wilson S Meng
Journal:  Mol Pharm       Date:  2022-08-24       Impact factor: 5.364

6.  Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology.

Authors:  Mustafa Bookwala; Priyanka Thipsay; Samir Ross; Feng Zhang; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2018-08-04       Impact factor: 5.571

7.  Crystal structure of tetra-aquabis(1,3-dimethyl-2,6-dioxo-3,7-di-hydro-1H-purin-9-ido)magnesium.

Authors:  Yabin Shi; Benyong Lou
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-28

Review 8.  Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.

Authors:  Isabela Fanelli Barreto Biscaia; Samantha Nascimento Gomes; Larissa Sakis Bernardi; Paulo Renato Oliveira
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

Review 9.  Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals.

Authors:  Mizraín Solares-Briones; Guadalupe Coyote-Dotor; José C Páez-Franco; Miriam R Zermeño-Ortega; Carmen Myriam de la O Contreras; Daniel Canseco-González; Alcives Avila-Sorrosa; David Morales-Morales; Juan M Germán-Acacio
Journal:  Pharmaceutics       Date:  2021-05-25       Impact factor: 6.321

Review 10.  Can (We Make) Bacillus thuringiensis Crystallize More Than Its Toxins?

Authors:  Guillaume Tetreau; Elena A Andreeva; Anne-Sophie Banneville; Elke De Zitter; Jacques-Philippe Colletier
Journal:  Toxins (Basel)       Date:  2021-06-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.